GATA factor mutations in hematologic disease

JD Crispino, MS Horwitz - Blood, The Journal of the American …, 2017 - ashpublications.org
GATA family proteins play essential roles in development of many cell types, including
hematopoietic, cardiac, and endodermal lineages. The first three factors, GATAs 1, 2, and 3 …

Cytogenetics of pediatric acute myeloid leukemia: a review of the current knowledge

J Quessada, W Cuccuini, P Saultier, M Loosveld… - Genes, 2021 - mdpi.com
Pediatric acute myeloid leukemia is a rare and heterogeneous disease in relation to
morphology, immunophenotyping, germline and somatic cytogenetic and genetic …

[图书][B] Leukaemia diagnosis

BJ Bain - 2017 - books.google.com
From the bestselling author, Barbara J. Bain, the new edition of this practical reference on
the principles of leukaemia diagnosis and classification has been fully updated, and …

Cytokine control of megakaryopoiesis

K Behrens, WS Alexander - Growth factors, 2018 - Taylor & Francis
Platelets are anuclear blood cells required for haemostasis and are implicated in other
processes including inflammation and metastasis. Platelets are produced by …

NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern

JDE de Rooij, IHIM Hollink, S Arentsen-Peters… - Leukemia, 2013 - nature.com
Cytogenetic abnormalities and early response to treatment are the main prognostic factors in
acute myeloid leukemia (AML). Recently, NUP98/NSD1 (t (5; 11)(q35; p15)), a …

[HTML][HTML] Hematopoietic cell transplantation in the treatment of pediatric acute myelogenous leukemia and myelodysplastic syndromes: guidelines from the American …

K Tarlock, ML Sulis, JH Chewning, JA Pollard… - … and Cellular Therapy, 2022 - Elsevier
The role of allogeneic hematopoietic stem cell transplantation (HCT) in the treatment of
acute myelogenous leukemia (AML) in children is reviewed and critically evaluated in this …

Current management of childhood acute myeloid leukemia

JE Rubnitz - Pediatric Drugs, 2017 - Springer
The outcome for children with acute myeloid leukemia (AML) has improved significantly over
the past 30 years, with complete remission and overall survival rates exceeding 90 and …

CD123 expression is associated with high-risk disease characteristics in childhood acute myeloid leukemia: a report from the Children's Oncology Group

AJ Lamble, L Eidenschink Brodersen… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE Increased CD123 surface expression has been associated with high-risk
disease characteristics in adult acute myeloid leukemia (AML), but has not been well …

Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome

AP Laurent, RS Kotecha, S Malinge - Leukemia, 2020 - nature.com
Structural and numerical alterations of chromosome 21 are extremely common in
hematological malignancies. While the functional impact of chimeric transcripts from fused …

Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study

JDE De Rooij, R Masetti… - Blood, The Journal …, 2016 - ashpublications.org
Genetic abnormalities and early treatment response are the main prognostic factors in acute
myeloid leukemia (AML). Acute megakaryoblastic leukemia (AMKL) is a rare subtype of …